US Broker Ratings

Apellis Pharmaceuticals (APLS) Stock Analysis: Biotechnology Innovator with 65% Upside Potential

Apellis Pharmaceuticals, Inc. (NASDAQ: APLS), a prominent player in the biotechnology sector, is attracting attention with its promising pipeline and significant potential upside. With a market..

Zai Lab Limited (ZLAB) Stock Analysis: Unpacking an Impressive 68% Potential Upside

Zai Lab Limited (NASDAQ: ZLAB) presents a compelling investment opportunity in the biotechnology sector, with analysts forecasting a considerable 68.26% potential upside from its current stock..

Concentra Group Holdings Parent (CON) Stock Analysis: Unveiling a 35% Upside Potential

Concentra Group Holdings Parent (NASDAQ: CON), a formidable player in the healthcare sector, presents an intriguing opportunity for investors eyeing the medical care facilities industry. With..

Crinetics Pharmaceuticals, Inc. (CRNX) Stock Analysis: Exploring an 82% Potential Upside in Biotech Innovations

Crinetics Pharmaceuticals, Inc. (NASDAQ: CRNX), a prominent player in the biotechnology sector, is making waves with its innovative approach to treating rare endocrine diseases. Based in..

Perrigo Company plc (PRGO) Stock Analysis: A 57.62% Upside in Focus Amidst Healthcare Market Dynamics

Perrigo Company plc (PRGO), a prominent player in the healthcare sector, particularly within the specialty and generic drug manufacturing industry, presents an intriguing opportunity for investors..

Sarepta Therapeutics, Inc. (SRPT): Investor Outlook with a 24.59% Potential Upside

Sarepta Therapeutics, Inc. (NASDAQ: SRPT) is a prominent player in the biotechnology sector, particularly in the niche field of genetic therapies for rare diseases. As of..

TransMedics Group, Inc. (TMDX) Stock Analysis: A 23% Upside Potential in the Innovative Organ Transplant Sector

TransMedics Group, Inc. (NASDAQ: TMDX) presents a compelling opportunity for investors seeking exposure to the healthcare sector, specifically within the medical devices industry. With a market..

iRhythm Technologies, Inc. (IRTC) Stock Analysis: 26% Revenue Growth and Promising Upside

iRhythm Technologies, Inc. (NASDAQ: IRTC) stands out as a formidable player in the healthcare sector, specifically within the medical devices industry. The company’s focus on developing..

Avidity Biosciences, Inc. (RNA) Stock Analysis: A Promising Biotech Play with 58.58% Potential Upside

Avidity Biosciences, Inc. (NASDAQ: RNA), a pioneering entity in the biotechnology industry, is garnering attention from investors with its innovative approach to RNA therapeutics. Specializing in..

Krystal Biotech, Inc. (KRYS) Stock Analysis: Uncovering a 22% Upside Potential Amidst Robust Revenue Growth

Krystal Biotech, Inc. (NASDAQ: KRYS), a leading player in the biotechnology sector, has caught the attention of investors with its promising genetic medicines portfolio and impressive..

Rhythm Pharmaceuticals, Inc. (RYTM) Investor Outlook: Exploring an 18.64% Potential Upside in the Rare Disease Biotech Space

Rhythm Pharmaceuticals, Inc. (NASDAQ: RYTM) stands as a noteworthy contender in the healthcare sector, particularly within the biotechnology industry. With a market capitalization of $6.59 billion,..

Charles River Laboratories (CRL) Stock Analysis: Navigating Market Volatility with a 19.64% Potential Upside

Charles River Laboratories International, Inc. (NYSE: CRL) stands at the forefront of the Healthcare sector, specializing in the Diagnostics & Research industry. With a market capitalization..

Cytokinetics, Incorporated (CYTK): Biotech Stock with 48% Upside Potential and Robust Revenue Growth

Cytokinetics, Incorporated (NASDAQ: CYTK) is making waves in the biotechnology sector with a market capitalization of $6.03 billion and a formidable presence in muscle biology drug..

Soleno Therapeutics, Inc. (SLNO) Stock Analysis: Exploring an 82.77% Potential Upside in the Biotech Sector

Soleno Therapeutics, Inc. (NASDAQ: SLNO), a clinical-stage biopharmaceutical company, stands at a pivotal moment in its journey, offering an intriguing opportunity for investors in the healthcare..

TG Therapeutics, Inc. (TGTX) Investor Outlook: Strong Revenue Growth and Promising Pipeline Signal Potential Upside

TG Therapeutics, Inc. (NASDAQ: TGTX) stands as a compelling figure in the biotechnology sector, captivating investors with its impressive revenue growth and innovative pipeline. Headquartered in..

ADMA Biologics Inc (ADMA) Stock Analysis: A Promising 86.16% Upside in the Biotech Sector

ADMA Biologics Inc (NASDAQ: ADMA), a prominent player in the biotechnology industry, is quietly navigating the healthcare sector with a focused mission to develop, manufacture, and..

BrightSpring Health Services, I (BTSG) Stock Analysis: A Strong Buy with 7.40% Upside Potential

BrightSpring Health Services, Inc. (BTSG), a pivotal player in the healthcare sector, is attracting attention from investors due to its robust growth metrics and positive analyst..

Lantheus Holdings, Inc. (LNTH) Stock Analysis: Unlocking a 71% Upside Potential with Innovative Diagnostics

Lantheus Holdings, Inc. (NASDAQ: LNTH) stands out in the healthcare sector, particularly within the niche of specialty and generic drug manufacturing. With a market capitalization of..

Bruker Corporation (BRKR) Stock Analysis: Exploring a 50% Upside Potential with Strong Buy Ratings

Bruker Corporation (NASDAQ: BRKR), a prominent player in the healthcare sector, specifically in the medical devices industry, is capturing investor interest with its substantial potential upside...

RadNet, Inc. (RDNT) Stock Analysis: Growth Potential in Diagnostic Imaging with a 4.45% Upside

RadNet, Inc. (NASDAQ: RDNT), a key player within the healthcare sector, specializes in providing outpatient diagnostic imaging services. The company operates through its Imaging Centers and..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds